Methylprednisolone pulse versus docetaxel in recurrent thymoma with myasthenia gravis

Methylprednisolone is more effective against thymoma than docetaxel for recurrent thymoma with MG, but has greater side effects. Docetaxel has similar MG efficacy compared to methylprednisolone, and with fewer side effects. The choice of treatment should be based on the patient's specific clinical situation.

Institutions

Hebei Medical University (CN)

Publication Details

Journal: Frontiers in Neurology
Published: 2025-12-19
DOI: https://doi.org/10.3389/fneur.2025.1615529
Primary Topic: Myasthenia Gravis and Thymoma
Type: article
Field-Weighted Citation Impact: 0.00

Funders

National Natural Science Foundation of China

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Methylprednisolone pulse versus docetaxel in recurrent thymoma with myasthenia gravis

Dec 19, 2025

Frontiers in Neurology

Myasthenia Gravis and Thymoma

article

Methylprednisolone pulse versus docetaxel in recurrent thymoma with myasthenia gravis

December 19, 2025article en

Abstract

Frontiers in NeurologyVol. 16

Hebei Medical University (CN)

National Natural Science Foundation of China

Good health and well-being

Openalex Percentile: Top 32%

Myasthenia Gravis and Thymoma

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Methylprednisolone pulse versus docetaxel in recurrent thymoma with myasthenia gravis · Frontiers in Neurology (2025) | TGRS Research Map | TGRS